MedPath

ZEPBOUND KWIKPEN

ZEPBOUND KWIKPEN

Approved
DIN Number

02557541

Drug Class

Human

Market Date

N/A

Company
HC

eli lilly canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02557541
AIG Number0164301004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BX16 TIRZEPATIDE
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification68:20.06
Health Canada Classification

ACTIVE INGREDIENTS (1)

TIRZEPATIDEActive
Strength: 12.5 MG / 0.6 ML
Monograph: TIRZEPATIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.